EUVIMEDEUVIMED entdecken
Crossref

A Structure‐Based Design Strategy with Pyrazole‐Pyridine Derivatives Targeting TNFα as Anti‐Inflammatory Agents: E‐Pharmacophore, Dynamic Simulation, Synthesis and In Vitro Evaluation

Debojyoti Halder, R S Jeyaprakash, Balaram Ghosh

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202400778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Debojyoti Halder und 2 weiteren Autor:innen. Beteiligte Einrichtung: Epigenetic Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad Campus, Shamirpet, Hyderabad, 500…. Hauptthemen laut MEDLINE: Pyrazoles, Pyridines, Tumor Necrosis Factor-alpha, Drug Design. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: BITS Pilani-Hyderabad Campus, and La Trobe, Australia ASCRIN PhD Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Any pathogenic attack, infection, or disease can initiate inflammation. It results in significant adverse consequences like inflammatory bowel disease, rheumatoid arthritis, etc. TNFα is one of the major pro‐inflammatory cytokines for the progression of inflammation—the present study designed a series of hybrid compounds consisting of the pyrazole‐pyridine moiety. Virtual screening was performed utilizing the e‐pharmacophore hypothesis with the co‐ligand of TNFα, screening, docking, and ADMET study. Induced fit docking, DFT analysis, and molecular dynamic simulation showed that the four best molecules ‐ Dh1‐ Dh4–showed crucial interaction with Tyrosine, higher dock scores, and better stability than Diclofenac. Following the synthesis of hit molecules, an in vitro albumin denaturation IC 50 of Dh1 was found to be 118.01 μM. Further in‐depth in vitro and in vivo analyses of these pyrazole‐pyridine small compounds may serve as potential space for creating new anti‐inflammatory leads.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazolesPyridinesTumor Necrosis Factor-alphaDrug DesignHumansMolecular Docking SimulationAnti-Inflammatory AgentsMolecular Dynamics SimulationMolecular StructureStructure-Activity RelationshipDensity Functional TheoryAnti-Inflammatory Agents, Non-SteroidalPharmacophore

Stichwörter der Autor:innen

Anti-inflammatory leadDatabaseDiclofenacInflammationMolecular dockingTNFα

Substanzen

PyrazolesPyridinesTumor Necrosis Factor-alphaAnti-Inflammatory AgentspyrazolepyridineAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Epigenetic Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad Campus, Shamirpet, Hyderabad, 500078, India.
  • Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.

Förderung

  • BITS Pilani-Hyderabad Campus, and La Trobe, Australia ASCRIN PhD Scholarship

Zitieren

APA

Halder, D., Jeyaprakash, R. S., & Ghosh, B. (2024). A Structure‐Based Design Strategy with Pyrazole‐Pyridine Derivatives Targeting TNFα as Anti‐Inflammatory Agents: E‐Pharmacophore, Dynamic Simulation, Synthesis and In Vitro Evaluation. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202400778

Vancouver

Halder D, Jeyaprakash RS, Ghosh B. A Structure‐Based Design Strategy with Pyrazole‐Pyridine Derivatives Targeting TNFα as Anti‐Inflammatory Agents: E‐Pharmacophore, Dynamic Simulation, Synthesis and In Vitro Evaluation. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202400778

BibTeX
@article{Halder2024,
  author = {Halder, Debojyoti and Jeyaprakash, R S and Ghosh, Balaram},
  title = {A Structure‐Based Design Strategy with Pyrazole‐Pyridine Derivatives Targeting TNFα as Anti‐Inflammatory Agents: E‐Pharmacophore, Dynamic Simulation, Synthesis and In Vitro Evaluation},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202400778}
}
Kostenlos starten →